SB606 Relative to insurance coverage for biomarker testing.
Relative to insurance coverage for biomarker testing.
Impact Score — How Does This Bill Affect You?
Overall Impact Score
Mixed
Scale: 1 (harmful) to 10 (beneficial)
Your Wallet
Mandating biomarker coverage helps patients avoid costly out-of-pocket diagnostic expenses, though premiums could see minor increases.
Your Community
Biomarker testing enables personalized medicine and better treatment outcomes, especially for cancer patients.
Your Freedom
Insurance mandate expands coverage options but adds requirements to health plans.
Status
Refer for Interim Study: Motion Adopted Voice Vote 05/14/2026 House Journal 13
Sponsor
Regina Birdsell (R)
The Short Version
Requires insurance coverage for biomarker testing, which helps diagnose diseases and guide targeted treatments, especially for cancer. Would ensure patients can access these increasingly important diagnostic tools.
Who's Behind This Bill?
Who Benefits
- ▲ Cancer patients
- ▲ Patients with complex diseases needing targeted treatment
- ▲ NH residents with health insurance
Who Pays the Price
- ▼ Insurance companies covering additional testing costs
Bill statuses as of May 2026. Check LegiScan or NH General Court for the latest.
This bill was auto-scored using AI analysis of the bill text and legislative data. Scores may be refined as we review more bills.